An earlier retrospective study conducted in Afghan refugees in North-Western Pakistan (Leslie et al., 2010) suggested that G6PD Med hemizygotes were protected against vivax malaria, but there were too few observations to substantiate a trend to lower infection rates in female heterozygotes. This evidence concerns the gene G6PD and Plasmodium vivax malaria.